Gurpremjit Singh
Papers
2
Total Citations
11
H-Index
2
About
Gurpremjit Singh is a rising figure in urologic oncology, whose work bridges the gap between advanced surgical techniques and cutting-edge artificial intelligence. His primary research focuses on improving outcomes for patients undergoing robotic surgery for prostate and kidney cancers. Singh’s most impactful contribution is his pioneering application of machine learning (ML) and neural network (NN) models to predict biochemical recurrence (BCR) after robot-assisted radical prostatectomy. This 2024 study, garnering 6 citations, demonstrated that AI models can outperform traditional statistical methods, offering a more personalized risk assessment for prostate cancer patients. In parallel, his 2023 investigation into robot-assisted partial nephrectomy in morbidly obese patients, drawing from the robust VCQI database with 5 citations, provides critical insights into surgical safety and efficacy for this challenging population. By integrating data-driven analytics with clinical practice, Singh is helping to define a new era of precision medicine in urologic surgery. His work not only advances predictive accuracy but also expands the boundaries of who can safely benefit from minimally invasive procedures, marking him as a researcher to watch in the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2